Decitabine and Ruxolitinib for Myelofibrosis
Phase 2
25
about 6.6 years
18+
1 site in WA
What this study is about
This trial is testing whether decitabine with ruxolitinib works before a stem cell transplant in treating myelofibrosis. The goal is to see if this treatment helps stop the growth of cancer cells in the bone marrow, improving blood counts and overall health.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Take Decitabine
- 3.Take Fedratinib
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
decitabine, fedratinib, pacritinib, ruxolitinib
injection, intravenous, oral (Oral Capsule), oral (Oral Tablet)
Secondary: Overall survival, Overall survival regardless of transplant status, Relapse-free survival, Relapse-free survival regardless of transplant status
diagnostic
Oncology